title: Effect of modest salt reduction on blood pressure, urinary albumin, and pulse wave velocity in white, black, and Asian mild hypertensives.
abstract: A reduction in salt intake lowers blood pressure. However, most previous trials were in whites with few in blacks and Asians. Salt reduction may also reduce other cardiovascular risk factors (eg, urinary albumin excretion, arterial stiffness). However, few well-controlled trials have studied these effects. We carried out a randomized double-blind crossover trial of salt restriction with slow sodium or placebo, each for 6 weeks, in 71 whites, 69 blacks, and 29 Asians with untreated mildly raised blood pressure. From slow sodium to placebo, urinary sodium was reduced from 165+/-58 (+/-SD) to 110+/-49 mmol/24 hours (9.7 to 6.5 g/d salt). With this reduction in salt intake, there was a significant decrease in blood pressure from 146+/-13/91+/-8 to 141+/-12/88+/-9 mm Hg (P<0.001), urinary albumin from 10.2 (IQR: 6.8 to 18.9) to 9.1 (6.6 to 14.0) mg/24 hours (P<0.001), albumin/creatinine ratio from 0.81 (0.47 to 1.43) to 0.66 (0.44 to 1.22) mg/mmol (P<0.001), and carotid-femoral pulse wave velocity from 11.5+/-2.3 to 11.1+/-1.9 m/s (P<0.01). Subgroup analysis showed that the reductions in blood pressure and urinary albumin/creatinine ratio were significant in all groups, and the decrease in pulse wave velocity was significant in blacks only. These results demonstrate that a modest reduction in salt intake, approximately the amount of the current public health recommendations, causes significant falls in blood pressure in all 3 ethnic groups. Furthermore, it reduces urinary albumin and improves large artery compliance. Although both could be attributable to the falls in blood pressure, they may carry additional benefits on reducing cardiovascular disease above that obtained from the blood pressure falls alone.
authors.affiliation: Blood Pressure Unit, Cardiac & Vascular Sciences, St. George's, University of London, Cranmer Terrace, London, UK. fhe@sgul.ac.uk
authors.forename: Feng J
authors.initials: FJ
authors.lastname: He
authors.forename: Maciej
authors.initials: M
authors.lastname: Marciniak
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Visagie
authors.forename: Nirmala D
authors.initials: ND
authors.lastname: Markandu
authors.forename: Vidya
authors.initials: V
authors.lastname: Anand
authors.forename: R Neil
authors.initials: RN
authors.lastname: Dalton
authors.forename: Graham A
authors.initials: GA
authors.lastname: MacGregor
mesh_terms: D000328:Adult; D000368:Aged; D000419:Albuminuria / Q000652:urine*; D044466:Asian People / Q000706:statistics & numerical data; D044383:Black People / Q000706:statistics & numerical data; D001794:Blood Pressure / Q000187:drug effects*; D018592:Cross-Over Studies; D004039:Diet, Sodium-Restricted; D004311:Double-Blind Method; D005260:Female; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D006973:Hypertension / Q000178:diet therapy* / Q000208:ethnology / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000097:blood / Q000652:urine; D012964:Sodium / Q000097:blood / Q000652:urine; D017673:Sodium Chloride, Dietary / Q000008:administration & dosage*; D013997:Time Factors; D044465:White People / Q000706:statistics & numerical data
chemical_list: D017673:Sodium Chloride, Dietary; D012964:Sodium; D011188:Potassium